Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Prostanoids are a group of bioactive lipids working as local mediators and include D, E, F and I types of prostaglandins (PGs) and thromboxanes. Prostacyclin (PGI2) acts on platelets and blood vessels to inhibit platelet aggregation and to cause vasodilatation, and is thought to be important for vascular homeostasis. Aspirin-like drugs, including indomethacin, which inhibit prostanoid biosynthesis, suppress fever, inflammatory swelling and pain, and interfere with female reproduction, suggesting that prostanoids are involved in these processes, although it is not clear which prostanoid is the endogenous mediator of a particular process. Prostanoids act on seven-transmembrane-domain receptors which are selective for each type. Here we disrupt the gene for the prostacyclin receptor in mice by using homologous recombination. The receptor-deficient mice are viable, reproductive and normotensive. However, their susceptibility to thrombosis is increased, and their inflammatory and pain responses are reduced to the levels observed in indomethacin-treated wild-type mice. Our results establish that prostacyclin is an antithrombotic agent in vivo and provide evidence for its role as a mediator of inflammation and pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, M. J., & de Beer, E. J. (1959) · Cited by 2,671
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, W. N., & de Beer, E. J. (1959) · Medical Entomology and Zoology · Cited by 2,132
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108 · cited 1×
“The generation of chimaeras and mutant mice has been describe”
BackgroundSelf-citationProstaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082 · cited 1×
“A similar abnormal mendelian ratio of male F 2 progeny was reported for cyclooxygenase-2-deficient mic”
BackgroundMalmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710 · cited 1×
“but also by facilitating pain transmission at the spina”
BackgroundThe Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Rat model of arterial thrombosis induced by ferric chloride
Kurz, K. D., Main, B. W., & Sandusky, G. E. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90106-m · Cited by 431 · cited 1×
“5% FeCl 3 solution, a procedure known to injure the endotheliu”
Background
Cited by
Items 401–500 of 783
Howe, L. R., Subbaramaiah, K., Kent, C. V., Zhou, X. K., Chang, S., Hla, T., Jakobsson, P., Hudis, C. A., & Dannenberg, A. J. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.04.002 · Cited by 30
Consequences of altered eicosanoid patterns for nociceptive processing in mPGES‐1‐deficient mice
Brenneis, C., Coste, O., Schmidt, R., Angioni, C., Popp, L., Nüsing, R. M., Becker, W., Scholich, K., & Geißlinger, G. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00110.x · Cited by 30
“Most importantly, studies employing knockout mice or using intrathecal administration of different prostaglandins demonstrated that not only PGE2 but also PGI2, PGD2, and PGF2 induce hyperalgesia or sensitize nociceptive neurons [11–14].”
BackgroundEndocannabinoid and Prostanoid Crosstalk in Pain
Buisseret, B., Alhouayek, M., Guillemot‐Legris, O., & Muccioli, G. G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.009 · Cited by 31
Wikström, K., Reid, H. M., Hill, M., English, K. A., O’Keeffe, M. B., Kimbembe, C. C., & Kinsella, B. T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.09.003 · Cited by 30
Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis
Kirkby, N. S., Raouf, J., Ahmetaj‐Shala, B., Liu, B., Mazi, S. I., Edin, M. L., Chambers, M. G., Korotkova, M., Wang, X., Wahli, W., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz290 · Cited by 30
Stitham, J., Gleim, S., Douville, K. L., Arehart, E. J., & Hwa, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604042200 · Cited by 32
Mehrabi, M. R., Ekmekçioğlu, C., Stanek, B., Thalhammer, T., Tamaddon, F., Pacher, R., Steiner, G., Wild, T., Grimm, M. F., Spieckermann, P. G., et al. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00317-x · Cited by 30
The choreography of cyclooxygenases in the kidney
FitzGerald, G. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216044 · Cited by 30
Spinal Prostaglandin Formation and Pain Perception Following Thoracotomy
McCrory, C. R., & Fitzgerald, D. J. (2004) · CHEST Journal · doi:10.1378/chest.125.4.1321 · Cited by 30
Quantitative metabolic profiling of lipid mediators
Balgoma, D., Checa, A., Sar, D. G., Snowden, S. G., & Wheelock, C. E. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200840 · Cited by 32
“PGI2 acts peripherally by binding the PGI2 receptor (IP), and has been reported to mediate both acute inflammation [151], and inflammatory pain transduction by producing hyperalgesia [150].”
BackgroundHarnessing the Platelet Signaling Network to Produce an Optimal Hemostatic Response
Brass, L. F., Tomaiuolo, M., & Stalker, T. J. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.02.002 · Cited by 29
Turner, E. C., Mulvaney, E. P., Reid, H. M., & Kinsella, B. T. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0374 · Cited by 29
Sasaki, Y., Kamiyama, S., Kamiyama, A., Matsumoto, K., Akatsu, M., Nakatani, Y., Kuwata, H., Ishikawa, Y., Ishii, T., Yokoyama, C., et al. (2015) · Scientific Reports · doi:10.1038/srep17376 · Cited by 29
Modulating platelet reactivity through control of RGS18 availability
Ma, P., Ou, K., Sinnamon, A. J., Jiang, H., Siderovski, D. P., & Brass, L. F. (2015) · Blood · doi:10.1182/blood-2015-04-640037 · Cited by 29
“Conversely, disrupting the gene that encodes PGI2 receptors in mice produces a prothrombotic phenotype.(4) PKA activation by cAMP leads to phosphorylation of a number of platelet proteins(35,36) including, as we show here, SPL.”
BackgroundBiosynthetic metabolomes of cysteinyl‐containing immunoresolvents
Jouvene, C. C., Shay, A. E., Soens, M., Norris, P. C., Haeggström, J. Z., & Serhan, C. N. (2019) · The FASEB Journal · doi:10.1096/fj.201902003r · Cited by 30
“To address visceral and abdominal pain, an abdominal constriction and pain-writhing response was induced in mice (41, 42).”
BackgroundVascular injury and modulation of MAPKs: A targeted approach to therapy of restenosis
Yu, P., Ferrari, G. M., Pirelli, L., Gulkarov, I. M., Galloway, A. C., Mignatti, P., & Pintucci, G. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.03.002 · Cited by 35
Wei, G., Kibler, K., Koehler, R. C., Maruyama, T., Narumiya, S., & Doré, S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.073 · Cited by 32
Self-citationEffects of Salt Loading on Blood Pressure in Mice Lacking the Prostanoid Receptor Gene
Watanabe, H., Katoh, T., Eiro, M., Iwamoto, M., Ushikubi, F., Narumiya, S., & Watanabe, T. (2004) · Circulation Journal · doi:10.1253/circj.69.124 · Cited by 29
Self-citationDemasi, M., Cleland, L. G., Cook‐Johnson, R. J., & James, M. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20429 · Cited by 29
Cyclooxygenase isoforms and atherosclerosis
Belton, O., & Fitzgerald, D. J. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005842 · Cited by 31
Smith, O. P. M., Battersby, S., Sales, K. J., Critchley, H., & Jabbour, H. N. (2005) · Endocrinology · doi:10.1210/en.2005-1073 · Cited by 29
Prostanoids in Cardiac and Vascular Remodeling
Ricciotti, E., Haines, P. G., Chai, W., & FitzGerald, G. A. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320045 · Cited by 28
Comprehensive Biochemical Analysis of Rare Prostacyclin Receptor Variants
Stitham, J., Arehart, E. J., Elderon, L., Gleim, S., Douville, K. L., Kasza, Z., Fetalvero, K. M., MacKenzie, T. A., Robb, J. F., Martin, K. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124933 · Cited by 28
Duffy, D. M., & VandeVoort, C. A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.048 · Cited by 28
“Mice lacking expression of the PGE receptors EP1 (27), EP3 (28), and EP4 (29) as well as receptors for thromboxane A2 (30) and prostacyclin (31) have no reproductive deficits.”
BackgroundPGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen
Simons, B., Ferrini, M. E., Carvalho, S., Bassett, D. J. P., Jaffar, Z. H., & Roberts, K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600275 · Cited by 28
Sharma, M., Sharma, R., McCarthy, E. T., Savin, V. J., & Srivastava, T. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.01.003 · Cited by 32
“Prostacyclin receptor KO mice have no phenotype [50] but prostacyclin synthase KO mice have elevated levels of PGE2 and a renal phenotype with cysts, sclerosis and vascular changes [51].”
Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs
Maillard, M. P., & Burnier, M. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.83 · Cited by 29
“However, this hypothesis is supported by several experimental data performed in transgenic mice lacking either the IP gene coding for the PGI2 receptor [34] or the EP2 receptor for PGE2 [35].”
BackgroundMethodCardiovascular risks of COX inhibition: current perspectives
Farooq, M., Haq, I. U., & Qureshi, A. S. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.8.1311 · Cited by 28
Jaffar, Z. H., Ferrini, M. E., Shaw, P. K., FitzGerald, G. A., & Roberts, K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101261 · Cited by 33
“Studies using mice deficient in the PGI2 receptor IP (IP 2/2 mice) provided strong evidence that PGI2 (also known as prostacyclin) exerts multiple effects in promoting as well as suppressing immune and inflammatory responses (17, 19, 20, 25, 26).”
BackgroundEventos cardiovasculares: um efeito de classe dos inibidores de COX-2
Araújo, L. F., Soeiro, A. D. M., Fernandes, J. D. L., & Junior, C. V. S. (2005) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2005001600016 · Cited by 40
Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice
Sugimoto, M., Arai, I., Futaki, N., Hashimoto, Y., Honma, Y., & Nakaike, S. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.002 · Cited by 27
Eicosanoids in Tumor Progression and Metastasis
Krishnamoorthy, S., & Honn, K. V. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_6 · Cited by 27
Sugimoto, Y., Fukada, Y., Mori, D., Tanaka, S., Yamane, H., Okuno, Y., Deai, K., Tsuchiya, S., Tsujimoto, G., & Ichikawa, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2606 · Cited by 27
“induced pleurisy (36), suggesting that PGI2 is the major prostanoid affecting vascular permeability in this model.”
BackgroundSelf-citationInhibition of Platelet Function by the Endothelium
Beaulieu, L. M., & Freedman, J. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00017-1 · Cited by 26
A Process‐Based Review of Mouse Models of Pulmonary Hypertension
Das, M., Fessel, J. P., Tang, H., & West, J. D. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.105030 · Cited by 29
“[22,23] Ptgir deficient mice are normotensive, but with increased susceptibility to thrombosis and reduced inflammatory responses.[24]”
BackgroundStitham, J., Arehart, E. J., Gleim, S., Li, N., Douville, K. L., & Hwa, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707413 · Cited by 26
“Recent studies using prostacyclin receptor (IP) knockout mice have revealed increased propensities towards thrombosis (Murata et al., 1997), intimal hyperplasia and restenosis (Cheng et al.”
BackgroundLipid mediators regulating pain sensitivity
Malan, T. P., & Porreca, F. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.008 · Cited by 28
Rowlands, D. K., Kao, C., & Wise, H. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704028 · Cited by 26
Pathogenesis and Mechanisms of Inflammation and Pain: An Overview
Botting, R. M., & Botting, J. H. (2000) · Clinical Drug Investigation · doi:10.2165/00044011-200019002-00001 · Cited by 25
GPCRs in context: sexual dimorphism in the cardiovascular system
Mouat, M. A., Coleman, J. L. J., & Smith, N. J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14160 · Cited by 25
“Studies in IP receptordeficient mice indicate that perturbations in receptor function cause vulnerability to CVD such as ischaemic heart disease due to enhanced thrombosis, without changes in BP (Murata et al., 1997), suggesting that the IP receptor is involved in acute responses rather than regulation of basal BP.”
BackgroundAnalgesic, anti-inflammatory, and anti-pyretic activity1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_9 · Cited by 29
Mitchell, J. A., Shala, F., Pires, M. E. L., Loy, R. Y., Ravendren, A., Benson, J., Urquhart, P., Nicolaou, A., Herschman, H. R., & Kirkby, N. S. (2021) · Science Advances · doi:10.1126/sciadv.abf6054 · Cited by 25
“Certainly, any effects of global deletion of cyclooxygenase-1 (19, 46) or the individual constrictor/ dilator prostanoid receptor IP (33), EP3 (47), or TP (48) on basal hemodynamics are minimal.”
BackgroundO’Keeffe, M. B., Reid, H. M., & Kinsella, B. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.04.010 · Cited by 25
“As one of the major products of cyclooxygenase (COX)-2, it acts as a potent proinflammatory mediator [2,3] and is abundantly produced during cardiac ischemia/reperfusion, offering cytoprotection [4].”
BackgroundThe Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B. S., Dalen, J. E., FitzGerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (1998) · CHEST Journal · Cited by 25
Rocca, B., Squellerio, I., Dragani, A., Veglia, F., Pagliaccia, F., Porro, B., Barbieri, S. S., Tremoli, E., Patrono, C., & Cavalca, V. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-10-0844 · Cited by 24
“60 [12–96]”
Chen, C., Su, C., Lai, M.-N., & Ng, L. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.047 · Cited by 24
Fujino, T., Yuhki, K., Yamada, T., Hara, A., Takahata, O., Okada, Y., Xiao, C., Ma, H., Karibe, H., Iwashima, Y., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704749 · Cited by 24
Self-citationProstaglandins: Modulators of Inflammation and Cardiovascular Risk
FitzGerald, G. A. (2004) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000130685.73681.8b · Cited by 24
“events do not occur.(20) Thus, augmented biosynthesis of PGI2 in human syndromes of platelet activation could indeed have functional relevance; theoretically, suppression of PGI2 alone could augment the risk in individuals otherwise predisposed to thrombosis.”
BackgroundRisk of Retinal Vein Occlusions in Patients Treated with Rofecoxib (Vioxx)
Meyer, C. H., Schmidt, J. C., Rodrigues, E. B., & Mennel, S. (2005) · Ophthalmologica · doi:10.1159/000085735 · Cited by 24
Ishimitsu, R., Yajima, T., Nishimura, H., Kawauchi, H., & Yoshikai, Y. (2002) · European Journal of Immunology · doi:10.1002/immu.200390021 · Cited by 24
Gohin, S., Sigaudo‐Roussel, D., Conjard‐Duplany, A., Dubourg, L. D., Saumet, J. L., & Fromy, B. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.267 · Cited by 23
“INTRODUCTION Prostacyclin (PGI2), the major cyclooxygenase (COX) product of arachidonic acid in the vascular endothelium, is a strong vasodilator on vascular beds (Funk, 2001; Fitzgerald, 2004) and acts as an inhibitor of platelet aggregation, a conclusion supported by an increase in thrombosis tendency in PGI2 recept…”
BackgroundMolloy, E. S., Morgan, M. P., McDonnell, B. P., O’Byrne, J., & McCarthy, G. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.10.003 · Cited by 23
Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor
Imanishi, J., Morita, Y., Yoshimi, E., Kuroda, K., Masunaga, T., Yamagami, K., Kuno, M., Hamachi, E., Aoki, S., Takahashi, F., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.035 · Cited by 23
“Further, writhing responses induced by acetic acid are generally regarded as dependent on PGI2 derived from COX-1, as the number of writhing responses has been reported to be decreased in COX-1-knockout mice [27] and IP-receptor-knockout mice [28] but not COX-2knockout mice [27].”
BackgroundLundblad, C., Grände, P., & Bentzer, P. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600533 · Cited by 23
“The main physiologic action of prostacyclin is suggested to be inhibition of aggregation of platelets and adhesion of leukocytes (Kobayashi et al, 2004; Moncada et al, 1976; Murata et al, 1997).”
BackgroundInfluentialEndothelial Control of Vasomotor Tone: The Kidney Perspective
Lamas, S., & Rodríguez-Puyol, D. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.02.002 · Cited by 23
Risk management profile of etoricoxib: an example of personalized medicine
Patrignani, P., Tacconelli, S., & Capone, M. L. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3209 · Cited by 23
“PGE 2 and prostacyclin, produced in the peripheral terminals of sensory nerve endings, are hyperalgesic and enhance nociception produced by other mediators (such as bradykinin) (Murata et al 1997; Nakao et al 2007).”
BackgroundAMANO, S., Tatsumi, K., Tanabe, N., Kasahara, Y., Kurosu, K., Takiguchi, Y., Kasuya, Y., Kimura, S., & Kuriyama, T. (2004) · Respirology · doi:10.1111/j.1440-1843.2004.00568.x · Cited by 24
Mokuno, Y., Takano, M., Matsuguchi, T., Nishimura, H., Washizu, J., Naiki, Y., Nimura, Y., & Yoshikai, Y. (1999) · Hepatology · doi:10.1002/hep.510300606 · Cited by 22
Wang, C., Wang, C., Ma, C., Huang, Q., Sun, H., Zhang, X., & Bai, X. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.09.018 · Cited by 22
Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells
Liu, Q., Xi, Y. T., Terry, T., So, S., Mohite, A. J., Zhang, J., Wu, G., Liu, X., Cheng, J., Ruan, K., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23035 · Cited by 22
“PGI2 provides vasoprotection through its vasodilative, anti-inflammatory, and antithrombotic properties (Murata et al., 1997; Liu et al., 2005).”
Gaba, M. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000243 · Cited by 23
“But these approaches are associated with some limitations, [9-14] so a real need exists to develop new antiinflammatory, analgesic agents with better efficacy, less toxicity and fewer side effects of gastric ulceration.”
BackgroundOmaña-Zapata, I., & Bley, K. R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02486-6 · Cited by 23
Harada, Y., Kawamura, M., Hatanaka, K., Saito, M., Ogino, M., Ohno, T., Ogino, K., & Qiu-Sheng, Y. (1998) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(98)00033-1 · Cited by 22
Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases
Strassheim, D., Sullivan, T., Irwin, D. C., Gerasimovskaya, E. V., Lahm, T., Klemm, D. J., Dempsey, E. C., Stenmark, K. R., & Karoor, V. (2021) · Cells · doi:10.3390/cells10123347 · Cited by 24
Increased bone mass in adult prostacyclin-deficient mice
Limjeerajarus, C. N., Yokoyama, C., Miura, H., Alles, N., Aoki, K., Ohya, K., & Morita, I. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0376 · Cited by 21
Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction
Strauss, J. F., & FitzGerald, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00004-4 · Cited by 30
Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
Nakanishi, T., Baldwin, H. S., Fineman, J. R., & Yamagishi, H. (2020) · Springer eBooks · doi:10.1007/978-981-15-1185-1 · Cited by 21
The roles of prostanoids in infection and sickness behaviors
Matsuoka, T., & Narumiya, S. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0622-3 · Cited by 21
Self-citationProstacyclin receptors: Transcriptional regulation and novel signalling mechanisms
Reid, H. M., & Kinsella, B. T. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.008 · Cited by 21
Kasza, Z., Fetalvero, K. M., Ding, M., Wagner, R. J., Ács, K., Guzman, A. K., Douville, K. L., Powell, R. J., Hwa, J., & Martin, K. A. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.006 · Cited by 21
“Recent genetic deletion studies in mice revealed that the absence of the prostacyclin receptor (IP) promotes intimal hyperplasia, atherosclerosis and hypercoaguability [6,7].”
BackgroundLow-Dose Prostacyclin Restores an Increased Protein Permeability after Trauma in Cat Skeletal Muscle
Bentzer, P., & nde, P. G. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000057238.75632.7f · Cited by 21
Prostanoids In Health and Disease; Lessons From Receptor-Knockout Mice
Kobayashi, T., & Narumiya, S. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_90 · Cited by 21
Self-citationCyclooxygenase-2 and Thromboxane Synthase in Non-Endocrine and Endocrine Tumors: A Review
Öngürü, Ö., Casey, M. B., Kajita, S., Nakamura, N., & Lloyd, R. V. (2005) · Endocrine Pathology · doi:10.1385/ep:16:4:253 · Cited by 21
Nakae, K., Saito, K., Iino, T., Yamamoto, N., Wakabayashi, M., Yoshikawa, S., Matsushima, S., Miyashita, H., Sugimoto, H., Kiba, A., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091967 · Cited by 21
“…accumulation in DRG neurons (Smith et al., 1998), thereby indicating that the IP receptor may represent a potential therapeutic target for pain and bladder disorders, both of which are induced by afferent nerve abnormalities (Murata et al., 1997; Sant and Theoharides, 1999; Yoshimura et al., 2002).”
BackgroundMammalian G-protein function in vivo: New insights through altered gene expression
Offermanns, S. (2006) · Springer eBooks · doi:10.1007/bfb0035551 · Cited by 23
Antimitogenesis Linked to Regulation of Skp2 Gene Expression
Stewart, S. A., Kothapalli, D., Yung, Y., & Assoian, R. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404271200 · Cited by 22
Urinary lipid profile of atopic dermatitis in murine model and human patients
Nagata, N., Hamasaki, Y., Inagaki, S., Nakamura, T., Horikami, D., Yamamoto‐Hanada, K., Inuzuka, Y., Shimosawa, T., Kobayashi, K., Narita, M., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100828r · Cited by 24
Self-citationShimizu, M., Yoshimura, S., Takizawa, S., Kohara, S., Inoko, H., & Takagi, S. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.06.011 · Cited by 20
Rudd, J. A., Qian, Y., Tsui, K. K. C., & Jones, R. L. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703090 · Cited by 20
“Of special note is the ®nding that mice with knock-out of the IP-receptor gene show reduced sensitivity to pain and less in¯ammatory oedema than wild-type mice (Murata et al., 1997).”
BackgroundThe Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway"
Félétou, M. (2011) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00032ed1v01y201105isp020 · Cited by 44
Loop Dialysis Catheter: A Technology for Chronic Spinal Dialysis in a Freely Moving Rat
Maršala, M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-770-x:269 · Cited by 22
Neurogenic Inflammation of the Bladder
Bjorling, D. E., Beckman, M., & Saban, R. (2003) · Springer eBooks · doi:10.1007/978-1-4419-8889-8_37 · Cited by 20
Oh‐ishi, S., Ueno, A., Matsumoto, H., Murata, T., Ushikubi, F., & Narumiya, S. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_39 · Cited by 20
Self-citationDiverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension
Clapp, L. H., Abu‐Hanna, J., & Patel, J. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-1185-1_5 · Cited by 21
Experimental ileitis alters prostaglandin biosynthesis in mesenteric lymphatic and blood vessels
Rehal, S., & von der Weid, P. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.11.001 · Cited by 21
Prostaglandin I2 Plays a Key Role in Zymosan-Induced Mouse Pleurisy
Yuhki, K., Ushikubi, F., Naraba, H., Ueno, A., Kato, H., Kojima, F., Narumiya, S., Sugimoto, Y., Matsushita, M., & Oh‐ishi, S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134494 · Cited by 19
“, 1998) and inflammatory pain transmission (Murata et al., 1997), respectively.”
BackgroundSelf-citationBlood-aqueous barrier in prostaglandin EP2 receptor knockout mice
Bhattacherjee, P., Mukhopadhyay, P., Tilley, S. L., Koller, B. H., Geoghgan, T., & Paterson, C. A. (2002) · Ocular Immunology and Inflammation · doi:10.1076/ocii.10.3.187.15601 · Cited by 19
Lee, R. H., Stefanini, L., & Bergmeier, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00018-7 · Cited by 22
Osanai, T., Akutsu, N., Fujita, N., Nakano, T., Takahashi, K., Guan, W., & Okumura, K. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h177 · Cited by 19
Inflammatory Diseases - A Modern Perspective
Nagal, A. (2011) · InTech eBooks · doi:10.5772/2437 · Cited by 19
Analgesic, Anti-inflammatory, and Anti-pyretic Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_9 · Cited by 20
Anti-Inflammatory Activity of Ghrelin in Human Carotid Artery Cells
Chow, K. B. S., Cheng, C. H. K., & Wise, H. (2009) · Inflammation · doi:10.1007/s10753-009-9149-8 · Cited by 19
“A lack of IP receptors or a decrease in prostacyclin production produces a prothrombotic state [12] allowing for a dominant role for TP receptors [13].”
BackgroundFamily 1 G protein-coupled receptor function in the CNS Insights from gene knockout mice
Karasinska, J. M., George, S. R., & O’Dowd, B. F. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00221-7 · Cited by 21
Sugimoto, M., Arai, I., Futaki, N., Hashimoto, Y., Sakurai, T., Honma, Y., & Nakaike, S. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00480.x · Cited by 18
“Moreover, PGE2 and PGI2 play an important role in edema formation (30) and inflammationrelated pain (31,32).”
BackgroundGe, J., Zhou, Y., Li, H., Zeng, R., Xie, K., Leng, J., Chen, X., Yu, G., Shi, X., Xu, Y., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324924 · Cited by 17
“53,54 Those facts indicate that the absence of PGI 2 / IP signaling may only play a minor, if any, role in inducing cardiovascular disorders in Pgis − / − mice.”
Amadio, P., Baldassarre, D., Tarantino, E., Zacchi, E., Gianellini, S., Squellerio, I., Amato, M., Weksler, B. B., Tremoli, E., & Barbieri, S. S. (2015) · The FASEB Journal · doi:10.1096/fj.14-268383 · Cited by 17
Dhouibi, R., Moalla, D., Ksouda, K., Salem, M. B., Hammami, S., Sahnoun, Z., Zeghal, K. M., & Affes, H. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1402352 · Cited by 17
Yamada, Y., Ohinata, K., Lipkowski, A. W., & Yoshikawa, M. (2010) · Peptides · doi:10.1016/j.peptides.2010.11.015 · Cited by 17
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice
Amadio, P., Rocca, B., Pesce, M., Machlus, K. R., Ranelletti, F. O., Gianellini, S., Weksler, B. B., Italiano, J. E., Tremoli, E., Barbieri, S. S., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-10-0872 · Cited by 17
“In fact, deletion of the IP augmented the response to an exogenous thrombogenic stimulus in mice (34, 47) and inhibition/ deletion of COX-2 affects vascular functionality and predisposes to microvascular and carotid artery occlusion (15, 48).”
BackgroundCOX-2 gene dosage-dependent defects in kidney development
Slattery, P., Frölich, S., Schreiber, Y., & Nüsing, R. M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00430.2015 · Cited by 17
Metadata
- Authors
- Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Osaka Women's and Children's Hospital (JP)
- Kitasato University (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1997-08-14
- Volume
- 388
- Issue
- 6643
- Pages
- 678-682
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1666619344
- Cited by
- 773
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 18 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 33
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- prostacyclin receptor, prostacyclin, prostanoids, pain perception, inflammation, thrombosis, indomethacin, prostaglandins, thromboxane, knockout mice, antithrombotic agents, vascular homeostasis
- MeSH terms
- Animals, Antithrombins, Blood Pressure, Inflammation, Mice, Inbred C57BL, Pain, Platelet Aggregation, Epoprostenol, Receptors, Prostaglandin, Thrombosis, Restriction Mapping, Dinoprostone, Mutagenesis, Gene Targeting, Receptors, Epoprostenol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.